UK watchdog calls for new AI healthcare legislation

London – The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that a newly approved medical technology will soon be incorporated into routine practice across the National Health Service (NHS), according to agency chief Lawrence Tallon in an interview with the BBC. The approval follows a comprehensive evaluation by the MHRA, which concluded that the technology meets the required safety and efficacy standards for widespread clinical use. Tallon said the agency is working closely with NHS trusts to coordinate the rollout, ensuring that hospitals and primary‑care facilities receive the necessary training and support to implement the new system effectively.

Implementation is slated to begin within the next few months, with the MHRA and NHS planning a phased deployment that prioritises high‑need specialties and regions. The agency expects the technology to enhance diagnostic accuracy and streamline treatment pathways, potentially reducing waiting times and improving patient outcomes. Tallon emphasized that ongoing monitoring will be conducted to assess performance and address any issues that arise during the transition, underscoring the commitment to maintaining high standards of patient safety as the innovation becomes a standard part of NHS care.